Get our Free Drug Patent Expiration Updates

Serving hundreds of leading biopharmaceutical companies globally:

Covington
Fuji
Citi
UBS
Julphar
Colorcon
McKesson
QuintilesIMS
Cantor Fitzgerald

Generated: September 19, 2018

DrugPatentWatch Database Preview

Fluvoxamine maleate - Generic Drug Details

see a sample report or, see our see our flat-rate plans

« Back to Dashboard

What are the generic drug sources for fluvoxamine maleate and what is the scope of fluvoxamine maleate freedom to operate?

Fluvoxamine maleate is the generic ingredient in three branded drugs marketed by Actavis Elizabeth, Anchen Pharms, Torrent Pharms Ltd, Jazz Pharms, Ani Pharms Inc, Apotex, Eci Pharms Llc, Mylan, Sun Pharm Industries, Synthon Pharms, Teva, Upsher-smith Labs, Watson Labs, Ani Pharms, and Solvay, and is included in nineteen NDAs. There is one patent protecting this compound and two Paragraph IV challenges. Additional information is available in the individual branded drug profile pages.

There are eleven drug master file entries for fluvoxamine maleate. Sixteen suppliers are listed for this compound.

Pharmacology for fluvoxamine maleate
Synonyms for fluvoxamine maleate
(1E)-5-methoxy-1-[4-(trifluoromethyl)phenyl]pentan-1-one O-(2-aminoethyl)oxime
(2-aminoethoxy)({5-methoxy-1-[4-(trifluoromethyl)phenyl]pentylidene})amine
(2-aminoethoxy)({5-methoxy-1-[4-(trifluoromethyl)phenyl]pentylidene})amine; but-2-enedioic acid
(E)-5-Methoxy-1-(4-(trifluoromethyl)phenyl)-1-pentanone O-(2-aminoethyl)oxime (Z)-2-butenedioate (1:1)
(E)-5-Methoxy-1-(4-(trifluoromethyl)phenyl)-pentan-1-one O-(2-aminoethyl) oxime
(E)-5-Methoxy-1-(4-(trifluoromethyl)phenyl)pentan-1-one O-(2-aminoethyl) oxime
(E)-5-Methoxy-1-(4-(trifluoromethyl)phenyl)pentan-1-one O-(2-aminoethyl) oxime maleate
(E)-5-Methoxy-1-(4-(trifluoromethyl)phenyl)pentan-1-one O-(2-aminoethyl)oxime
(E)-5-Methoxy-1-(4-(trifluoromethyl)phenyl)pentan-1-one O-(2-aminoethyl)oxime maleate
(E)-5-Methoxy-1-[4-(trifluoromethyl)phenyl)-1-pent
(E)-5-Methoxy-1-[4-(trifluoromethyl)phenyl]-1-pentanone O-(2-Aminoethyl)oxime Maleate
(E)-5-Methoxy-1-[4-(triflurormethyl)phenyl]-1-pentanone O-(2-Aminoethyl)oxime Maleate
(E)-5-Methoxy-4'-(trifluormethyl)valerophenon-O-(2-aminoethyl)oxim
(E)-Fluvoxamine Maleate
(Z)-2-butenedioic acid; 2-[(E)-[5-methoxy-1-[4-(trifluoromethyl)phenyl]pentylidene]amino]oxyethanamine
(Z)-but-2-enedioic acid; 2-[(E)-[5-methoxy-1-[4-(trifluoromethyl)phenyl]pentylidene]amino]oxyethanamine
(Z)-but-2-enedioic acid;2-[(E)-[5-methoxy-1-[4-(trifluoromethyl)phenyl]pentylidene]amino]oxyethanamine
1-Pentanone, 5-methoxy-1-(4-(trifluoromethyl)phenyl)-, O-(2-aminoethyl)oxime, (E)-
1-Pentanone, 5-methoxy-1-(4-(trifluoromethyl)phenyl)-, O-(2-aminoethyl)oxime, (E)-, (Z)-2-butenedioate (1:1)
1-Pentanone, 5-methoxy-1-(4-(trifluoromethyl)phenyl)-, O-(2-aminoethyl)oxime,(E)-, (Z)-2-butenedioate (1:1)
2-[({(1E)-5-methoxy-1-[4-(trifluoromethyl)phenyl]pentylidene}amino)oxy]ethanamine (2Z)-but-2-enedioate
2-[({5-methoxy-1-[4-(trifluoromethyl)phenyl]pentylidene}amino)oxy]ethanamine
2-[(E)-[5-methoxy-1-[4-(trifluoromethyl)phenyl]pentylidene]amino]oxyethanamine
39F183
5-methoxy-1-[4-(trifluoromethyl)phenyl]-1-pentanone O-(2-aminoethyl)oxime
5-Methoxy-4'-(trifluoromethyl)valerophenone (E)-O-(2-aminoethyl)oxime, maleate (1:1)
5-Methoxy-4'-trifluoromethylvalerophenone (E)-O-2-aminoethyloxime monomaleate
54739-18-3
54739-18-3 (Parent)
54739-20-7
5LGN83G74V
61718-82-9
61718-82-9 (maleate)
739F183
917096-37-8
A830353
A833394
AB0016707
AB00513735_05
AB00513735_06
AB00514702
AB2000054
AC-1679
AC-9541
AC1NT50J
AC1Q4JNU
AK-51735
AK-51736
AKOS015961142
AKOS016003882
AN-39241
AN-5830
AS-11790
AS-15332
AX8016087
AX8021384
BC226180
BDBM50028091
BG0368
BIDD:GT0609
BPBio1_001199
BRD-K53517854-050-03-2
BSPBio_001089
C07571
C15H21F3N2O2
C15H21F3N2O2.C4H4O4
C19H25F3N2O6
CAS-54739-18-3
CC-28527
CCG-204586
CCG-213494
CHEBI:5138
CHEBI:5139
CHEMBL1409
CHEMBL814
CPD000466268
CS-1839
CS-1840
D00824
D03HFG
D07984
D0M5JI
Depromel
DSSTox_CID_24002
DSSTox_GSID_44002
DSSTox_RID_80097
DTXSID2044002
DTXSID3042558
DU-23000
DU23000
Dumirox
Dumyrox
EU-0100495
F 2802
F0858
Faverin
Fevarin
Floxyfral
Fluvoxamina
Fluvoxamina [INN-Spanish]
fluvoxamine
Fluvoxamine (INN)
Fluvoxamine (maleate)
Fluvoxamine [INN:BAN]
Fluvoxamine for system suitability, European Pharmacopoeia (EP) Reference Standard
Fluvoxamine maleate (JP17/USAN)
Fluvoxamine maleate [USAN:USP]
Fluvoxamine maleate [USAN]
Fluvoxamine maleate, 1.0 mg/mL in methanol ((as free base)), certified reference material
Fluvoxamine maleate, European Pharmacopoeia (EP) Reference Standard
Fluvoxamine Maleate, pharmaceutical secondary standard; traceable to USP, PhEur, BP
Fluvoxamine maleate, solid
Fluvoxamine maleate, United States Pharmacopeia (USP) Reference Standard
fluvoxamine-CR
Fluvoxaminum
Fluvoxaminum [INN-Latin]
FVX
HMS1571G11
HMS2098G11
HMS3261D11
HY-B0103
HY-B0103A
I01-8382
J90043
KB-209259
KB-209260
Lopac0_000495
LS-101999
LS-102000
Luvox
Luvox (TN)
Luvox CR
Luvox, Floxyfral
maleic acid; 2-[(E)-[5-methoxy-1-[4-(trifluoromethyl)phenyl]pentylidene]amino]oxyethanamine
Maveral
MK-264
MLS000028469
MLS000758271
MLS001076285
MLS001304717
MLS001401391
MolPort-003-666-870
MolPort-005-943-374
NCGC00018193-04
NCGC00018193-05
NCGC00018193-06
NCGC00018193-07
NCGC00018193-08
NCGC00018193-11
NCGC00021870-04
NCGC00021870-05
NCGC00093897-01
NCGC00093897-02
NCGC00261180-01
NSC 309469
NSC-309469
NSC-759602
NSC309469
NSC759602
O4L1XPO44W
O893
Pharmakon1600-01505604
Prestwick2_000995
Prestwick3_000995
s1336
SAM001246977
SCHEMBL33983
SCHEMBL35225
SME 3110
SME-3110
SMR000058449
SMR000466268
SMR000653482
SR-01000075613
SR-01000075613-1
ST24035070
TL8003932
Tox21_110837
Tox21_110837_1
Tox21_500495
UNII-5LGN83G74V
UNII-O4L1XPO44W
ZINC12466082

US Patents and Regulatory Information for fluvoxamine maleate

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Teva FLUVOXAMINE MALEATE fluvoxamine maleate TABLET;ORAL 075893-002 Sep 10, 2002 AB RX No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Actavis Elizabeth FLUVOXAMINE MALEATE fluvoxamine maleate TABLET;ORAL 075901-003 Dec 28, 2000 DISCN No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Upsher-smith Labs FLUVOXAMINE MALEATE fluvoxamine maleate TABLET;ORAL 075887-001 Jan 5, 2001 DISCN No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Apotex FLUVOXAMINE MALEATE fluvoxamine maleate TABLET;ORAL 075902-001 May 7, 2001 AB RX No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Actavis Elizabeth FLUVOXAMINE MALEATE fluvoxamine maleate CAPSULE, EXTENDED RELEASE;ORAL 091482-002 Nov 18, 2013 AB RX No Yes ➤ Sign Up ➤ Sign Up ➤ Sign Up
Eci Pharms Llc FLUVOXAMINE MALEATE fluvoxamine maleate TABLET;ORAL 075900-001 Feb 23, 2006 DISCN No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Ani Pharms Inc FLUVOXAMINE MALEATE fluvoxamine maleate TABLET;ORAL 075897-003 Jan 25, 2001 AB RX No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial

see a sample report or, see our see our flat-rate plans

Expired US Patents for fluvoxamine maleate

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Solvay LUVOX fluvoxamine maleate TABLET;ORAL 020243-001 Dec 5, 1994 ➤ Sign Up ➤ Sign Up
Solvay LUVOX fluvoxamine maleate TABLET;ORAL 020243-004 Dec 5, 1994 ➤ Sign Up ➤ Sign Up
Solvay LUVOX fluvoxamine maleate TABLET;ORAL 020243-003 Dec 5, 1994 ➤ Sign Up ➤ Sign Up
Solvay LUVOX fluvoxamine maleate TABLET;ORAL 020243-002 Dec 5, 1994 ➤ Sign Up ➤ Sign Up
Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial

see a sample report or, see our see our flat-rate plans

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Covington
Fuji
Citi
UBS
Julphar
Colorcon
McKesson
QuintilesIMS
Cantor Fitzgerald

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.